Doug has joined DSW from a career in industry. After qualifying as a management accountant in the steel industry, Doug moved to Accenture; he subsequently pursued a career with early stage businesses in the technology and life science sectors. He has experience on the transaction side having managed both fundraisings and M&A. In addition, he has considerable operational experience gained as a hands-on CFO in numerous companies and is well versed in the challenges businesses face as they progress from start-up through to revenue generation. Doug also brings public markets experience having worked with several AIM businesses, latterly as CFO of University of Manchester spinout, SkinBioTherapeutics plc, which he led through an IPO in 2017.
Outside of work, Doug is a keen cyclist and can be found most weekends at a Peak District café enjoying coffee and flapjack.